MIOTOLAN ( furazabol )
| Substance:
furazabol |
| Trade
Names:
|
| Miotolan |
1 mg tab.; |
Daiichi Seiyaku Japan |
Furazobol, known by its trade name, Miotolan, is a synthetic derivative of dihydrotestosterone. Until 1990 this steroid was not detectable during any doping tests and could thus be taken by athletes even on the day of a competition. When looking at the application of Miotolan you learn even more unusual things: This steroid is used as a lipid reducer. It is suitable for long-term treatment of arteriosclerosis and hypercholesterolemia. Miotolan reduces the cholesterol level and increases the "good" HDL value. In Japan Miotolan is a standard treatment to lower cholesterol levels.
This steroid does not cause water and salt retention and does not aromatize. Since the tablets are effective for only a brief period of time they must be taken several times a day. Miotolan has a predominantly androgenic effect and only a very low repression of the body's own testosterone production. Although it is potentially hepatoxic a possible reduced liver function seems unlikely if the daily manufacturer-recommended dose of 2-6 mg is not exceeded. Since athletes use considerably higher dosages the risk of liver poisoning cannot be excluded. The usual question-What is a performance improving dosage?-is difficult to answer. It is difficult because we do not know anybody who has ever taken this compound and be-cause technical literature does not have anything to report in this regard either. The daily dosage should be at least 10-20 tablets, that is 10-20 mg/day. Due to its low substance amount per tablet and its high cost, this steroid will probably not be successful with body-builders. (Possible doubts by readers that this steroid perhaps does not exist are inappropriate.) However, this steroid re-ally does exist.
MIOTOLAN ( furazabol )
MIOTOLAN ( furazabol )